|
|
Volumn 17, Issue 3, 2000, Pages 543-549
|
|
Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
FOLINIC ACID;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
GASTROINTESTINAL DISEASE;
HEAD AND NECK TUMOR;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIFE TABLE;
MALE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEUTROPENIA;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
REMISSION;
RISK FACTOR;
SQUAMOUS CELL CARCINOMA;
STOMATITIS;
SURVIVAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
GASTROINTESTINAL DISEASES;
HEAD AND NECK NEOPLASMS;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUCOVORIN;
LIFE TABLES;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NEUTROPENIA;
REMISSION INDUCTION;
RISK FACTORS;
STOMATITIS;
SURVIVAL ANALYSIS;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0034266013
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.17.3.543 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
